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It is clear from our commentary (Goldman 
and Silbergeld 2013), that we disagree with 
Lutter et al. (2013) about whether the pub-
lic disclosure of all raw data used by the 
U.S. Environmental Protection Agency (EPA) 
for making regulatory decisions for chemicals 
is necessary to ensure the scientific basis for 
such decisions, and about the extent to which 
pre emptive dis closure (prior to any request) 
is practical. However, the most important 
disagreement between us is the basis asserted 
by Lutter et al. in their commentary for this 
change in policy. Lutter et al. argued that it 
is necessary for the U.S. EPA—and anyone 
else who desires to do so—to reanalyze all 
data used in their assessments in order to 
“replicate” the findings and conclusions of 
the original investigators. 
Lutter et al. (2013) repeatedly used the 
terms “replicability” and “replication” as 
synony mous with an “independent analy-
sis” of raw data from an existing study. 
Replication in science is quite different; it 
involves performance of an independent study 
with the same hypothesis and then testing 
the extent to which this independent study 
reaches the same conclusions. Recalculation 
of study statistics or other reanalysis of an 
existing study data set is not a replication. 
Designing and conducting a replication study 
does not require access to raw data from the 
original study; this would abrogate the con-
cept of independence. Moreover, an indepen-
dent study will by defini tion utilize different 
sets of animal models or human populations, 
and as a consequence may employ different 
statistical techniques.
Their second argument is that disclosure 
of raw data will assist in identifying sources 
of scientific bias. We consider this unlikely 
because the most important sources of bias 
are usually related to problems in study design 
or limitations of the data collected. This is not 
identifiable through data recalculation; how-
ever, this type of bias can usually be identified 
in the text of the original study publication. 
Lutter et al. (2013) noted (correctly) that 
applicants to the U.S. EPA for pesticide regis-
trations must provide raw data from regula-
tory testing as part of the package submitted 
to the U.S. EPA. This is a very special case, in 
that these studies are neither peer reviewed nor 
accessible to the public because of the protec-
tion sought by industry and extended by law 
for confidential business information (CBI). 
The assumption of bias related to these stud-
ies is not unreasonable, given that they are 
conducted by or on behalf of commercial enti-
ties seeking to obtain pesticide registration. 
These studies are rarely published in the scien-
tific literature or in any way subject to inde-
pendent peer review other than review by the 
U.S. EPA. Many scientists and public policy 
practitioners consider the CBI cloak as a major 
impedi ment to transparency and confidence. 
Industry could demonstrate their commitment 
to transparency by declining this protection, 
thereby increasing the confidence of all. 
Finally, Lutter et al. (2013) attempted to 
support their proposal by claiming that jour-
nals [Nature and the Proceedings of the National 
Academy of Sciences of the United States 
(PNAS)] and an expert body (the Bipartisan 
Policy Center) agree with them. However, 
these bodies have neither supported the con-
cept of requiring that all raw data be reported 
to the the U.S. EPA nor that the U.S. EPA 
carry out its own independent recalculation. 
Rather, Nature and PNAS require authors to 
agree to make data sets (as well as materials 
and protocols) available to editors, and to oth-
ers, upon request (Nature Publishing Group 
2012; PNAS 2012). One of us (L.R.G.) was 
a member of the Science for Policy Project; its 
final report (Bipartisan Policy Center 2009) 
also recommended this practice. Many jour-
nals require data, such as DNA and protein 
sequences, macro molecular structures, micro-
array data, and crystallo graphic data, to be 
made available on publicly accessible data-
bases, but most of these are not “raw data” in 
the sense that Lutter et al. proposed. Nature 
also recommends that authors submit clinical 
trials data to external clinical trials databases 
(Nature Publishing Group 2012). 
In summary, we disagree with the argu-
ment that raw data from every study used by 
the U.S. EPA to support a regu la tory assess-
ment should be made available to the agency 
and to the public. This proposal does not 
serve the purpose of “replication” or identi-
fica tion of bias, as asserted by Lutter et al. 
(2013). In practice, it may generate obstacles 
to good science and discourage researchers 
from studying issues of importance in 
environ mental health. This proposal would 
also limit the U.S. EPA from using the results 
of research published in the peer-reviewed 
scientific litera ture by placing studies off-
limits if the authors did not submit raw 
data sets to the the U.S. EPA. 
Finally, there is no obvious need for these 
changes. When the U.S. EPA has determined 
a need to reanalyze data, the current regula-
tory practice has not impeded such activities. 
Past history indicates that difficult cases are 
rare and do not warrant an intrusive and 
burden some new requirement for the auto-
matic submission of data from all studies. 
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We appreciate the attention paid by Goldman 
and Silbergeld (2013) to the issue of data dis-
closure and agree that there has been “increased 
demand for transparency and disclosure of the 
data used by the U.S. EPA [Environmental 
Protection Agency] to make evaluations that 
support regu latory decisions.”
In their letter, Goldman and Silbergeld 
contend primarily that “replication” in science 
means to independently repeat a prior study 
to see if the same results can be obtained. 
They suggest that public availability of the 
prior study’s data is unnecessary because a sub-
sequent study will generate its own data. In 
2011, a special section of Science (Vol. 334, 
No. 6060) addressed replicability and repro-
ducibility and made two general points. First, 
“replication,” as defined by Goldman and 
Silbergeld, while perhaps the cornerstone of 
the scientific method, can be difficult in many 
settings because of the uniqueness of the pre-
cise conditions surrounding field observations, 
the expense and time required to collect data 
(e.g., for longitudinal studies), and ethical con-
straints (e.g., Jasny et al. 2011). Second, in 
those cases where conduct of a second experi-
ment may be impossible or infeasible, review 
and reanalysis of the first study’s data is still 
a meaningful step along the “reproducibility 
spectrum,” assists in under standing the differ-
ences between competing analyses, and “may 
be sufficient to verify the quality of the scien-
tific claims” (Peng 2011; see also Ioannides 
and Khoury 2011; Santer et al. 2011).
Other empirical work also supports the 
view that data availability promotes repro-
ducibility. In empirical economics, a disci-
pline that uses large-scale statistical models 
broadly similar to those of epidemiologists, a 
famous study of replication of peer-reviewed 
research suggested that inadvertent errors may 
be “commonplace rather than rare occur-
rences” (Dewald et al. 1986). The American 
Economic Review (AER 2013) subsequently 
adopted a policy “to publish papers only if 
the data used in the analysis are clearly and 
precisely documented and are readily available 
to any researcher for purposes of replication.” 
Further, the AER conducted a recent evalu-
ation of its policy and reported that about 
80% of 39 sampled papers met the spirit of 
the data availability policy (Glandon 2010). 
Importantly, independent efforts at replication 
of 9 selected papers found no serious errors 
(almost exact replication for 5 studies and 
“several small discrepancies … immaterial to 
the conclusions” for another 4.) This result 
represents a marked improvement relative to 
the results of the original 1986 study of repli-
cation. The difference is presumably attribut-
able, at least in part, to the difference in care 
and quality of work associated with the AER’s 
current policy of data availability. Although 
analytic methods under lying papers published 
in the AER are different from those used in 
chemical evaluation, the experience of the 
AER suggests that there is merit in promoting 
data availability for the purpose of improving 
the reliability of the results of published, peer-
reviewed scien tific papers, at least in disci plines 
that use complex statistical models. 
Finally, we, like Goldman and Silbergeld, 
“disagree with the argument that raw data 
from every study used by the U.S. EPA to 
support a regulatory assessment should be 
made available to the agency and to the pub-
lic.” Unlike Goldman and Silbergeld, we 
recom mend that the U.S. EPA, when it uses 
results of a published study in a regulatory 
assessment, ask the authors for under lying 
data (Lutter et al. 2013). If the U.S. EPA does 
not receive such data, it should explain how it 
used the study results in light of the fact that 
data sufficient to assess reproduci bility was 
not forthcoming. We believe our approach 
would facilitate and not obstruct good science 
and that it would not discourage researchers 
from studying issues of importance in environ-
mental health. Moreover, it would not, as 
Goldman and Silbergeld state,
limit the U.S. EPA from using the results of 
research published in the peer-reviewed scien-
tific literature by placing studies off-limits if 
the authors did not submit raw data sets to the 
U.S. EPA. 
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